← Eichor
Study identifier: NCT07017192 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

OPPOSED (anteriOr hiP arthroPlasty regiOnal aneSthEsia stuDy) Study

Condition: Hip Replacement Surgery · Hip Replacement, Total · Hip Pain  ·  Sponsor: A.O.U. Città della Salute e della Scienza

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Main indications for total hip arthroplasty (THA) are degenerative osteoarthritis of the coxofemoral joint, osteonecrosis of the hip, congenital disorders such as dysplasia and inflammatory arthritis. More recently, surgery using the direct anterior approach is getting popularity: this method, in fact, granting a significant sparing of the hip muscles, is associated with favorable results compared to other techniques, such as a lower risk of dislocation, limitated damage to soft tissues with better recovery and early discharge. Patients undergoing this procedure may although experience moderate to severe postoperative pain in the first few hours (with peaks observed in the first 12 hours), as well as potential complications such as nausea and vomiting related to opioids use. It has been shown that adequate pain control influences early mobilization and rehabilitation, ensuring a quicker recovery. The role of regional anesthesia techniques has been established in almost all areas of orthopedic surgery, and in particularly in the management of postoperative pain following hip replacement surgery, but definitive data are missing with regard to direct anterior approach. Regional anesthesia consists of infiltrating local anesthetics in sites (fascial planes or nerves), in order to limit or even eliminate the use of traditional painkillers, with a significant reduction in the side effects. The aim of this study is to compare the impact of two techniques, the Suprainguinal Fasci…

This description comes directly from the study's public registry record.

Talk to the study team

Marco Ulla, MD  ·  0039-3397548673  ·  marco.ulla@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

AOU Città della Salute e della ScienzaTorino, TO, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07017192